33652000-5categoryAntineoplastic and immunomodulating agents tenders
5 open antineoplastic and immunomodulating agents tenders right now within General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. CPV 33652000-5 classifies antineoplastic and immunomodulating agents across European public procurement.
Antineoplastic and immunomodulating agents tenders closing soon
Sorted by deadlineRaamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening
Ziekenhuis aan de Stroom vzw (ZAS)TED Member StatesSource
€2.3M01 Jul 2026
By the numbers
Open now
5
Notices all-time
1,757
Typical value (median)
€617k
€308k – €967k
Last published
29 May 2026
Top sources
Buyer and value figures for this level are aggregated from sub-codes and may be approximate.
Frequently asked questions
- What is CPV code 33652000-5?
- CPV 33652000-5 (Antineoplastic and immunomodulating agents) is a Common Procurement Vocabulary code used across European public procurement to classify antineoplastic and immunomodulating agents contracts. Buyers tag notices with this code so suppliers can find relevant tenders.
- How many antineoplastic and immunomodulating agents tenders are open right now?
- Tender Radar is currently tracking 5 open antineoplastic and immunomodulating agents (CPV 33652000-5) tenders, out of 1,757 notices published all-time.
- What is the typical value of a antineoplastic and immunomodulating agents contract?
- The median estimated value of a antineoplastic and immunomodulating agents (CPV 33652000-5) contract is around €616,776. Values vary widely by buyer and scope.
- Where are antineoplastic and immunomodulating agents tenders published?
- Antineoplastic and immunomodulating agents (CPV 33652000-5) notices are aggregated from sources including Portal BASE, TED Member States, PLACSP (Spain), alongside other European procurement portals tracked by Tender Radar.
Track antineoplastic and immunomodulating agents tenders automatically
Tender Radar monitors CPV 33652000-5 tenders across 15+ European procurement portals and matches them to your company profile. Get relevant antineoplastic and immunomodulating agents opportunities delivered as they publish.